ZFIN ID: ZDB-FISH-150901-7868
Fish name: AB + MO1-arl6ip1
Genotype: AB
Targeting Reagent: MO1-arl6ip1
HUMAN DISEASE MODELED by AB + MO1-arl6ip1
No data available
GENE EXPRESSION
Gene expression in AB + MO1-arl6ip1
RNA expression
Expressed Gene Structure Conditions Figures
arl6ip1 standard conditions Fig. 2 with image from Huang et al., 2009
bmp4 standard conditions Fig. 4 with image from Tu et al., 2012
crestin standard conditions Fig. 6 with imageFig. 7 with image from Tu et al., 2012
dlx2a standard conditions Fig. 2 with image from Tu et al., 2012
dlx3b standard conditions Fig. 4 with image from Tu et al., 2012
foxd3 standard conditions Fig. 5 with image from Tu et al., 2012
msx1b standard conditions Fig. 4 with image from Tu et al., 2012
opn1lw2 standard conditions Fig. 3 with image from Huang et al., 2009
pax3a standard conditions Fig. 4 with image from Tu et al., 2012
phox2bb standard conditions Fig. 7 with image from Tu et al., 2012
rho standard conditions Fig. 3 with image from Huang et al., 2009
snai1b standard conditions Fig. 5 with image from Tu et al., 2012
sox10 standard conditions Fig. 5 with image from Tu et al., 2012
tfap2a standard conditions Fig. 5 with image from Tu et al., 2012
wnt8a standard conditions Fig. 4 with image from Tu et al., 2012
Protein expression
Antibody Antigen Genes Structure Conditions Figures
zn-8 standard conditions Fig. 3 with image from Huang et al., 2009
Ab6-BrdU chemical treatment: 5-bromo-2'-deoxyuridine Fig. 3 with image from Huang et al., 2009
Ab1-arl6ip1 arl6ip1 standard conditions Fig. 2 with image from Huang et al., 2009
Reporter gene expression No data available
PHENOTYPE
Phenotype in AB + MO1-arl6ip1
Phenotype Conditions Figures
apoptotic process increased occurrence, abnormal standard conditions Fig. 8 with image from Tu et al., 2012
apoptotic process occurrence, normal standard conditions Fig. 8 with image from Tu et al., 2012
camera-type eye development arrested, abnormal standard conditions Fig. 2 with image from Huang et al., 2009
camera-type eye photoreceptor cell differentiation disrupted, abnormal chemical treatment: 5-bromo-2'-deoxyuridine Fig. 3 with image from Huang et al., 2009
cell cycle disrupted, abnormal chemical treatment: 5-bromo-2'-deoxyuridine Fig. 3 with image from Huang et al., 2009
cranial neural crest decreased size, abnormal standard conditions Fig. 5 with imageFig. 6 with image from Tu et al., 2012
cranial neural crest cell mislocalised, abnormal standard conditions Fig. 6 with image from Tu et al., 2012
dorsal root ganglion neuron decreased amount, abnormal standard conditions Fig. 3 with image from Tu et al., 2012
enteric nervous system development disrupted, abnormal standard conditions Fig. 7 with image from Tu et al., 2012
enteric neuron decreased amount, abnormal standard conditions Fig. 3 with image from Tu et al., 2012
enteric neuron decreased length, abnormal standard conditions Fig. 7 with image from Tu et al., 2012
enteric neuron mislocalised, abnormal standard conditions Fig. 7 with image from Tu et al., 2012
epibranchial ganglion neuron decreased amount, abnormal standard conditions Fig. 3 with image from Tu et al., 2012
ethmoid cartilage absent, abnormal standard conditions Fig. 2 with image from Tu et al., 2012
extension decreased length, abnormal standard conditions Fig. 1 with image from Tu et al., 2012
Fig. 2 with image from Huang et al., 2009
eye decreased size, abnormal standard conditions Fig. 2 with image from Huang et al., 2009
eye morphology, abnormal standard conditions Fig. 1 with image from Tu et al., 2012
gut morphology, abnormal standard conditions Fig. 2 with image from Huang et al., 2009
head decreased size, abnormal standard conditions Fig. 1 with image from Tu et al., 2012
head flat, abnormal standard conditions Fig. 2 with image from Huang et al., 2009
hindbrain morphology, abnormal standard conditions Fig. 2 with image from Huang et al., 2009
iridophore decreased amount, abnormal standard conditions Fig. 1 with image from Tu et al., 2012
mandibular arch skeleton decreased size, abnormal standard conditions Fig. 1 with image from Tu et al., 2012
melanocyte decreased amount, abnormal standard conditions Fig. 1 with image from Tu et al., 2012
melanocyte migration disrupted, abnormal standard conditions Fig. 1 with image from Tu et al., 2012
neural crest cell decreased amount, abnormal standard conditions Fig. 8 with image from Tu et al., 2012
neural crest cell apoptotic process occurrence, normal standard conditions Fig. 8 with image from Tu et al., 2012
neural crest cell migration process quality, abnormal standard conditions Fig. 6 with image from Tu et al., 2012
neural crest cell migration involved in autonomic nervous system development disrupted, abnormal standard conditions Fig. 7 with image from Tu et al., 2012
neurocranial trabecula decreased size, abnormal standard conditions Fig. 2 with image from Tu et al., 2012
optic cup decreased size, abnormal standard conditions Fig. 2 with image from Huang et al., 2009
optic tectum morphology, abnormal standard conditions Fig. 2 with image from Huang et al., 2009
otic vesicle decreased size, abnormal standard conditions Fig. 1 with image from Tu et al., 2012
pectoral fin absent, abnormal standard conditions Fig. 2 with image from Tu et al., 2012
pectoral fin morphology, abnormal standard conditions Fig. 2 with image from Huang et al., 2009
pericardium edematous, abnormal standard conditions Fig. 1 with image from Tu et al., 2012
Fig. 2 with image from Huang et al., 2009
pharyngeal arch 3-7 morphology, abnormal standard conditions Fig. 2 with image from Huang et al., 2009
pharyngeal arch cartilage absent, abnormal standard conditions Fig. 2 with image from Tu et al., 2012
pigment cell irregular spatial pattern, abnormal standard conditions Fig. 2 with image from Huang et al., 2009
pigmentation disrupted, abnormal standard conditions Fig. 2 with image from Huang et al., 2009
pneumatic duct morphology, abnormal standard conditions Fig. 2 with image from Huang et al., 2009
post-vent region curved dorsal, abnormal standard conditions Fig. 2 with image from Huang et al., 2009
post-vent region decreased length, abnormal standard conditions Fig. 1 with image from Tu et al., 2012
Fig. 2 with image from Huang et al., 2009
retina decreased size, abnormal standard conditions Fig. 3 with image from Huang et al., 2009
retina morphology, abnormal standard conditions Fig. 2 with image from Huang et al., 2009
retina axon malformed, abnormal standard conditions Fig. 3 with image from Huang et al., 2009
retina development in camera-type eye disrupted, abnormal standard conditions Fig. 3 with image from Huang et al., 2009
retina layer formation disrupted, abnormal standard conditions Fig. 3 with image from Huang et al., 2009
retina morphogenesis in camera-type eye disrupted, abnormal standard conditions Fig. 3 with image from Huang et al., 2009
retinal bipolar neuron differentiation delayed, abnormal standard conditions Fig. 3 with image from Huang et al., 2009
retinal bipolar neuron differentiation disrupted, abnormal chemical treatment: 5-bromo-2'-deoxyuridine Fig. 3 with image from Huang et al., 2009
solid lens vesicle decreased size, abnormal standard conditions Fig. 1 with image from Tu et al., 2012
somite border irregular spatial pattern, abnormal standard conditions Fig. 2 with image from Huang et al., 2009
swim bladder morphology, abnormal standard conditions Fig. 2 with image from Huang et al., 2009
trunk deformed, abnormal standard conditions Fig. 2 with image from Huang et al., 2009
trunk neural crest cell mislocalised, abnormal standard conditions Fig. 6 with image from Tu et al., 2012
trunk neural crest cell migration delayed, abnormal standard conditions Fig. 6 with image from Tu et al., 2012
vagal neural crest decreased size, abnormal standard conditions Fig. 7 with image from Tu et al., 2012

CITATIONS  (3)